Pentamidine Isethionate Inhalant
Product Images NDC 13925-522

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pentamidine Isethionate (NDC 13925-522). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Seton Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pentamidine Structure (Pentamidine Structure)

Chemical structure diagram of Pentamidine Isethionate showing molecular formula C19H24N4O2 with two molecules of C2H6O4S and an additional component with formula C2H5OH and CH2SO3H, indicating the isethionate salt form. The molecular weight 592.68 is displayed.*

FDA Label Image

Vial Label (Pentamidine Vial Label)

Label for Pentamidine Isethionate inhalant solution, 300 mg per vial, lyophilized. The label includes usage instructions for nebulizer use after reconstitution with sterile water, storage conditions, preservative status, and single-dose vial designation. The product is labeled by Seton Pharmaceuticals with NDC 13925-522.*

FDA Label Image

Seton Logo (Seton Logo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.